Pulse Biosciences, Inc. Ratios

Ratios Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin -38.79%-1,606.29%
EBT Margin -4,778.33%-43,728.95%-4,489.42%-8,357.86%
EBIT Margin -4,878.33%-43,828.95%-4,443.86%-8,293.86%
EBITDA Margin -4,777.82%-43,733.33%-4,489.35%-8,357.86%
Operating Margin -4,878.33%-43,828.95%-4,443.86%-8,293.86%
Net Margin -4,778.33%-43,728.95%-4,489.42%-8,357.86%
FCF Margin -11,933.82%-5,521.46%-5,419.73%-3,539.47%-31,408.77%-3,845.84%-6,773.43%
Efficiency
Assets Average 50.22M68.52M68.52M95.81M
Equity Average 33.63M21.06M21.06M79.61M
Invested Capital 22.89M44.36M-2.25M44.36M114.86M
Asset Utilization Ratio 0.030.01
Leverage & Solvency
Debt to Equity -28.91
Debt Ratio 0.83
Equity Ratio 0.550.75-0.030.750.87
Valuation
Enterprise Value 86.55M254.81M194.65M278.77M596.64M394.47M41.98M628.73M964.40M
Market Capitalization 278.77M604.65M438.84M103.12M673.10M1,082.44M
Return Ratios
Return on Sales -47.78%-437.29%-44.89%-83.58%
Return on Capital Employed -1.45%-0.93%-0.70%-0.66%
Return on Assets -1.27%-0.85%-0.62%-0.56%
Return on Equity -1.89%-2.78%-2.00%-0.67%